Enhancement of the antidepressant action of fluoxetine by folic acid: a randomised, placebo controlled trial
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Background A consistent finding in major depression has been a low plasma and red cell folate which has also been linked to poor response to antidepressants. The present investigation was designed to investigate whether the co-administration of folic acid would enhance the antidepressant action of fluoxetine. Methods 127 patients were randomly assigned to receive either 500 microg folic acid or an identical looking placebo in addition to 20 mg fluoxetine daily. All patients met the DSM-III-R criteria for major depression and had a baseline Hamilton Rating Scale (17 item version) score for depression of 20 or more. Baseline and 10-week estimations of plasma folate and homocysteine were carried out. Results Patients receiving folate showed a significant increase in plasma folate. This was less in men than in women. Plasma homocysteine was significantly decreased in women by 20.6%, but there was no significant change in men. Overall there was a significantly greater improvement in the fluoxetine plus folic acid group. This was confined to women where the mean Hamilton Rating Scale score on completion was 6.8 (S.D. 4. 1) in the fluoxetine plus folate group, as compared to 11.7 (S.D. 6. 7) in the fluoxetine plus placebo group (P 50% reduction in score) as compared to 61.1% of women who received placebo supplement (P Limitations and conclusions Folic acid is a simple method of greatly improving the antidepressant action of fluoxetine and probably other antidepressants. Folic acid s…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“higher folate levels at baseline appear associated with a better response [42].”
From Complementary and alternative medicine therapies for perinatal depression (2014) · cites this paper as [42]
Citations
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study
Murray, C. J., & Lopez, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07495-8 · Cited by 4,492
Homocysteine and Cardiovascular Disease
Refsum, H., Ueland, P. M., Nygård, O., & Vollset, S. E. (1998) · Annual Review of Medicine · doi:10.1146/annurev.med.49.1.31 · Cited by 2,180
Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials
Collaboration, H. L. T. (1998) · BMJ · doi:10.1136/bmj.316.7135.894 · Cited by 1,084
Depression and the Course of Coronary Artery Disease
Glassman, A. H., & Shapiro, P. A. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.1.4 · Cited by 676
Enhancement of recovery from psychiatric illness by methylfolate
Godfrey, P. S. A., Toone, B. K., Bottiglien, T., Laundy, M., Reynolds, E. H., Carney, M. W. P., Flynn, T. G., & Chanarin, I. (1990) · The Lancet · doi:10.1016/0140-6736(90)91942-4 · Cited by 389
Depressive Symptoms and Increased Risk of Stroke Mortality Over a 29-Year Period
Everson, S. A., Roberts, R. E., Goldberg, D. E., & Kaplan, G. A. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.10.1133 · Cited by 355
Serum Folate and Risk of Fatal Coronary Heart Disease
Morrison, H. I. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03530480035037 · Cited by 308
Folate, vitamin B12, and homocysteine in major depressive disorder
(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.3.426 · Cited by 287
Identification of Cognitive Impairment in the Elderly: Homocysteine Is an Early Marker
Lehmann, M., Gottfries, C. G., & Regland, B. (1999) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017092 · Cited by 245
Cited by
PRACTICE GUIDELINE FOR THE Treatment of Patients With Major Depressive Disorder
Gelenberg, A. J., Freeman, P. B., Markowitz, J. C., Rosenbaum, J. F., Thase, M. E., Trivedi, M. H., & Rhoads, R. S. (2010) · Cited by 1,510
Haroon, E., Raison, C. L., & Miller, A. H. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.205 · Cited by 1,000
“Of note, similar augmentation of antidepressant efficacy has been found with folic acid and folinic acid (Leucovorin), a metabolically active form of folic acid that is readily converted to L-methylfolate and is used to supplement folic acid in patients undergoing treatment with methotrexate (Coppen and Bailey, 2000;…”
BackgroundVitamin B12, folic acid, and the nervous system
Reynolds, E. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70598-1 · Cited by 860
Depression and cardiovascular disease: mechanisms of interaction
Joynt, K. E., Whellan, D. J., & O'Connor, C. M. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00568-7 · Cited by 507
Homocysteine and folate metabolism in depression
Bottiglieri, T. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.06.021 · Cited by 459
Metadata
- Authors
- Coppen, A., & Bailey, J.
- Affiliations
- West Park Hospital (GB)
- Corresponding author
- Coppen, Alec
- Venue
- Journal of Affective Disorders
- Publisher
- Elsevier BV
- Published
- 2000-11
- Volume
- 60
- Issue
- 2
- Pages
- 121-130
- ISSN
- 0165-0327 (ISSN-L)
- OpenAlex
- W2011323334
- Cited by
- 337
- References
- 21
- Citations by year
- 2026: 7 · 2025: 5 · 2024: 7 · 2023: 12 · 2022: 13 · 2021: 8 · 2020: 7 · 2019: 7 · 2018: 11 · 2017: 10 · 2016: 14 · 2015: 13 · 2014: 17 · 2013: 23 · 2012: 15
- FWCI
- 7.13
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Journal of Affective Disorders (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Nursing › Nutrition and Dietetics › Folate and B Vitamins Research
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- folic acid, fluoxetine, major depressive disorder, antidepressant efficacy, plasma folate, homocysteine, sex differences, antidepressant response, folic acid supplementation
- MeSH terms
- Adult, Depressive Disorder, Major, Major Depressive Disorder, Double-Blind Method, Drug Therapy, Combination, Female, Fluoxetine, Folic Acid, Homocysteine, Humans, Male, Middle Aged, Psychiatric Status Rating Scales, Sex Factors, Vitamin B 12, Treatment Outcome, Antidepressive Agents, Second-Generation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Enhancement of the antidepressant action of fluoxetine by folic acid: a randomised, placebo controlled trial. https://app.cochat.ai/papers/10.1016/s0165-0327(00)00153-1
- The paper
- Coppen, A., & Bailey, J. (2000). Enhancement of the antidepressant action of fluoxetine by folic acid: a randomised, placebo controlled trial. Journal of Affective Disorders. https://doi.org/10.1016/s0165-0327(00)00153-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.